(NYSE: QGEN) Qiagen Nv's forecast annual revenue growth rate of 4.76% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.61%.
Qiagen Nv's revenue in 2025 is $2,040,067,000.On average, 7 Wall Street analysts forecast QGEN's revenue for 2025 to be $453,091,300,480, with the lowest QGEN revenue forecast at $448,801,164,500, and the highest QGEN revenue forecast at $456,043,544,450. On average, 7 Wall Street analysts forecast QGEN's revenue for 2026 to be $478,333,400,025, with the lowest QGEN revenue forecast at $474,117,930,000, and the highest QGEN revenue forecast at $484,917,282,850.
In 2027, QGEN is forecast to generate $513,044,579,385 in revenue, with the lowest revenue forecast at $508,600,104,740 and the highest revenue forecast at $520,900,613,350.